Letter to the Editor: Portal hypertension and variceal bleeding in patients with liver cancer: Evidence gaps for prevention and management

Dhiraj Tripathi^{1

2}, Thomas Reiberger^{3

4}

Affiliations

¹ Liver Unit, University Hospitals Birmingham, Birmingham, UK.
² Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
³ Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
⁴ Vienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria.

Comment

Dhiraj Tripathi et al. Hepatology. 2024.

. 2024 Jan 1;79(1):E1-E2.

doi: 10.1097/HEP.0000000000000359. Epub 2023 Mar 30.

Dhiraj Tripathi^{1

2}, Thomas Reiberger^{3

4}

¹ Liver Unit, University Hospitals Birmingham, Birmingham, UK.
² Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
³ Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
⁴ Vienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria.

No abstract available

Comment in

Reply: Portal hypertension and variceal bleeding in patients with liver cancer: Evidence gaps for prevention and management.
Allaire M, Thabut D. Allaire M, et al. Hepatology. 2024 Jan 1;79(1):E3. doi: 10.1097/HEP.0000000000000358. Epub 2023 Mar 13. Hepatology. 2024. PMID: 36896969 No abstract available.

Portal hypertension and variceal bleeding in patients with liver cancer: Evidence gaps for prevention and management.
Allaire M, Thabut D. Allaire M, et al. Hepatology. 2024 Jan 1;79(1):213-223. doi: 10.1097/HEP.0000000000000291. Epub 2023 Jan 13. Hepatology. 2024. PMID: 36631021 Review.

1. Allaire M, Thabut D. Portal hypertension and variceal bleeding in patients with liver cancer: Evidence gaps for prevention and management. Hepatology. 2023.
1. de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Baveno VII. Baveno VII renewing consensus in portal hypertension. J Hepatol. 2022;76:959–74.
1. Villanueva C, Albillos A, Genesca J, Garcia-Pagan JC, Calleja JL, Aracil C, et al. Beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): A randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2019;393:1597–608.
1. Villanueva C, Torres F, Sarin SK, Shah HA, Tripathi D, Brujats A, et al. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis. J Hepatol. 2022;77:1014–25.
1. Castera L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology. 2010;51:828–35.